NCT00892541View on ClinicalTrials.gov

A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS Paliperidone

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

November 30, 2004

Conditions
Schizophrenia
Interventions
DRUG

ER OROS paliperidone

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00892541 - A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS Paliperidone | Biotech Hunter | Biotech Hunter